* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download nail discolouration
Survey
Document related concepts
Transcript
How to Treat PULL-OUT SECTION www.australiandoctor.com.au Complete How to Treat quizzes online www.australiandoctor.com.au/cpd to earn CPD or PDP points. INSIDE Anatomy and physiology Black or brown Leukonychia Blue or green Yellow Red or orange the authors Dr Emma Mooney dermatology trainee, Austin Hospital, Heidelberg, Victoria. Dr Caroline Kronborg medical registrar, Alfred Health, Prahran, Victoria. Background CHROMONYCHIA is a common presentation to both GPs and dermatologists. It refers to alteration in the colour of the nail — either involving the nail plate or subungual tissue. It may be the result of overproduction of pigment or melanin or deposition on or alteration in the surface of the nail. The nail provides a protective surface covering the fingertips while allowing sensory discrimination and enhanced dexterity. Further, the cosmetic appearance of the nails is of social importance, and nail disorders may lead to psychological distress. Chromonychia may represent a wide range of colours, including black or brown (melanonychia), white (leukonychia), red (erythronychia), or even blue, yellow or green. The causes of chromonychia are diverse, ranging from exogenous dermatological conditions to infection and congenital disease. In this article, we review the different ways a discoloured nail may present to general practice and their clinical assessment and management. cont’d next page nail discolouration Associate Professor Anne Howard head of dermatology, Western Hospital, Footscray, Victoria and dermatology consultant, nail clinic, Skin and Cancer Foundation, Carlton, Victoria. Copyright © 2014 Australian Doctor All rights reserved. No part of this publication may be reproduced, distributed, or transmitted in any form or by any means without the prior written permission of the publisher. For permission requests, email: [email protected] www.australiandoctor.com.au 14 November 2014 | Australian Doctor | 25 How To Treat – Nail discolouration Anatomy and physiology FINGERNAILS grow at an average rate of 0.1mm per day and toenails at half this speed. Any insult to the nail plate or matrix will result in a deformity that may be present for many months before growing out completely. The nail unit consists of the nail plate, nail bed, lateral nail folds, cuticle (the eponychium) and hyponychium (figure 1). The nail plate adheres firmly to the nail bed, and its undersurface interdigitates longitudinally with corresponding grooves on the nail bed. The nail unit overlies the terminal phalanx. Due to the close proximity of the nail matrix to the distal interphalangeal joint, any change to the joint or bone can result in nail-plate distortion. About a quarter of the nail is covered by the proximal nail fold, from which the nail plate emerges. The nail plate is bordered on each side by the lateral nail folds and covered proximally by the eponychium. The germinal epithelial matrix is responsible for the majority of nail production. The lunula is the distal aspect of the germinal matrix and can be identified as a white half-moon at the proximal nail. Nail rigidity is due to hard keratins comprised primarily of sulfur bonds, but the nail plate also contains calcium, phosphate, zinc, iron and copper. Nail plate Nail bed Hyponychium Lunula Nail plate Figure 1: Anatomy of the nail unit showing the nail plate, nail bed, lateral nail fold, cuticle (eponychium) and hyponychium. Adapted from image courtesy of R. Martell. Lateral nail fold Nail matrix Cuticle Proximal nail fold Black or brown MELANONYCHIA — black or brown nail discolouration — results from melanin deposition by melanocytes; it is not age- or gender-specific and is usually benign. These melanocytes are usually contained in the nail matrix and normally lie dormant. Melanin production may be increased when existing melanocytes are activated (melanocyte activation) or as a result of an increase in the number of melanocytes (melanocyte hyperplasia). Melanonychia may present as a tan, brown or black longitudinal streak within the nail plate that extends from the nail fold to the free edge of the nail (longitudinal melanonychia), may involve the entire nail plate (complete melanonychia) or may run transverse across the nail (transverse melanonychia). Table 1: Causes of melanocyte activation* Benign racial pigmentation Pregnancy A Age > 50 years old Inflammatory Psoriasis Lichen planus Chronic paronychia Bowen’s disease BCC B Brown to black, blurred irregular borders, breadth > 3mm C Changes of melanonychia or nail plate morphology (sudden, recent or rapid) D Digit: single digit, especially thumb, great toe or index finger Hyperthyroidism Addison’s disease Cushing’s syndrome HIV Haemosiderosis Porphyria cutanea tarda E Extension of pigment into nail fold (Hutchinson’s sign of the nail) F Family or personal history of melanoma and/or dysplastic naevus syndrome Syndromes Laugier-Hunziker Peutz-Jeghers Begins in a single digit during the fourth to seventh decade Iatrogenic Radiation exposure Phototherapy Drugs (eg, doxorubicin, cyclophosphamide, etoposide, methotrexate, hydroxyurea, minocycline, chloroquine) Systemic Red flags for longitudinal melanonychia due to melanoma: Involves the proximal nailfold (Hutchinson’s sign of the nail) * Adapted from Andre and Lateur, ‘Pigmented nail disorders’, 2006.29 Melanocyte activation Activation of existing melanocytes leads to increased production of melanin, which results in pigmentation of surrounding onychocytes. Melanocyte activation is associated with many conditions — listed in table 1. It is usually benign. One condition associated with melanocyte activation is benign racial pigmentation. This condition often occurs in multiple fingernails or toenails and is most common in Fitzpatrick skin types III-VI. It may be more common in Afro-Caribbean patients, particularly in the form of longitudinal melanonychia.1 It is unusual in Caucasians. Figure 2 shows benign racial pigmentation in the nails of men of a Turkish and an Indian ethnicity. Pregnancy may also cause melanocyte activation, affecting the skin and the nails. It may result in dark bands of pigment through one or multiple nails. It usually resolves following delivery. Local causes Local inflammatory conditions may cause melanocyte activation — most commonly seen with psoriasis, chronic paronychia and lichen planus. While these conditions may present with melanonychia, they are also associated with a variety of other nail changes, including red, orange and yellow discolouration. On resolution or 26 | Australian Doctor | 14 November 2014 Features concerning for melanoma of the nail unit (The ABCDEF mnemonic8) Physiologic A Figure 2: Benign racial pigmentation: A: in the toenails of a Turkish male. B: in the fingernails of an Indian male. B control of the inflammatory condition, chromonychia often resolves. Carcinoma may invade and disrupt the germinal matrix, resulting in melanonychia. Squamous cell carcinoma in situ (Bowen’s disease) and basal cell carcinoma of the nail are uncommon. Such malignant processes will often cause identifiable surrounding cutaneous change and secondary nail distortion. Treatment is surgi- cal; Mohs’ micrographic surgery is often utilised to achieve adequate local clearance while minimising loss of digital function. Systemic and syndromic causes Systemic diseases or syndromes can present with melanonychia. Toenails and fingernails are often involved and may present as multiple bands of longitudinal melanonychia. Endocrine disorders, such www.australiandoctor.com.au Develops abruptly in a previously normal nail Becomes suddenly darker or wider Occurs in a person who gives a history of digital trauma Has blurred, not straight lateral borders Is accompanied by nail dystrophy Has a wider base of the band (proximally) than distally as hyperthyroidism, Addison’s disease and Cushing’s syndrome, have been associated with melanonychia in some patients. Other associated conditions include HIV, haemosiderosis and porphyria cutanea tarda. There are a few rare syndromes associated with melanonychia. Laugier-Hunziker syndrome is a benign, sporadic disorder of unknown cause characterised by macular pigmentation of the buccal mucosa, lips and melanonychia. It may be of cosmetic concern but is not associated with internal malignancy. This differs from Peutz-Jeghers syndrome, which is an autosomal dominant condition associated with an increased risk of gastrointestinal malignancy. It too may result in melanocytic macules of the oral mucosa as well as the hands, feet and nails. Iatrogenic causes Iatrogenic causes of melanonychia include drugs, phototherapy and both systemic and local irradiation. Cytotoxic agents are often implicated and include cyclophosphamide, etoposide, methotrexate, doxorubicin and hydroxyurea.2-4 Cyclophosphamide may cause a diffuse or longitudinal black melanonychia or a grey dyschromia at the proximal nail plate. Doxorubicin may cause transverse bands of dark brown and white dyschromia, and hydroxyurea may produce a dark brown band of pigmentation distally. Chloroquine may cause diffuse blue-black dyschromia. 26 The antiretroviral agent zidovudine may cause longitudinal melanonychia. 27 Minocycline is known to cause diffuse blue-black chromonychia with relative sparing of the lunula.28 Following cessation of the causative agent, chromonychia will often resolve, but resolution may take months. Melanocyte hyperplasia Melanocytic hyperplasia refers to an increase in the number of melanocytes in the nail matrix. The process may occur in benign conditions (lentigo or subungual melanocytic naevi) or malignant conditions (melanoma). It is sometimes difficult to differentiate between a benign and a malignant process clinically, resulting in diagnostic delay and subsequent poor prognosis. A high index of suspicion is required, and concerning features warrant prompt specialist referral (see ‘Features concerning for melanoma of the nail’ and ‘Red flags for longitudinal melanonychia due to melanoma’). cont’d page 28 How To Treat – Nail discolouration from page 26 Benign causes Subungual naevi may be acquired or congenital and are more common in children (figure 3). They differ from lentigo because of the nested nature of melanocytes. Subungual naevi can present de novo in childhood or teenage years. Lentigo is more common in adults. If a new linear band of blackbrown pigment occurs in an adult, a biopsy may be required. Serial photography can be helpful if the history of evolution is unclear, especially in conjunction with dermoscopic images. Dermoscopic evaluation of naevi will reveal regular parallel lines of pigment often on a brown background. Melanoma Melanoma involving the nail plate is most commonly seen in the fourth to seventh decade. It represents 1-3% of melanoma in the Caucasian population and 15-20% of melanomas in the African-American population.5,6 Between 45% and 60% of subungual melanomas arise in the hand and 40-55% in the foot. The thumb and great toe are more commonly affected. Melanoma is thought to originate from the nail matrix and not from the nail bed itself.7 Acral lentiginous melanoma is the most common cause of malignant melanocyte hyperplasia; superficial spreading or nodular melanoma may also cause melanonychia. Subungual melanoma is classically seen as new-onset longitudinal melanonychia. It may also present with change in width or colour of exist- Figure 3: Benign subungual naevus of the middle finger that had been present since childhood. Figure 4: Surgery exposing melanoma extending into the nail fold, clinically identified by Hutchinson’s sign of the nail. ing longitudinal melanonychia. It should be noted that longitudinal melanonychia is most commonly caused by physiological conditions, even though it may suggest an underlying subungual melanoma. The box, ‘Red flags for longitudinal melanonychia due to melanoma’, lists features that should arouse suspicion for further invest- alteration in the nail matrix nor the nail bed; rather, it refers to an exogenous process affecting the more superficial layers of the nail plate, such as in white superficial onychomycosis or nail varnish. Occupational history, family history, drug history and history of possible exposure to heavy metals should be elicited. Examination should be targeted, looking for signs of liver or renal failure, malnutrition and signs of systemic disease. Screening blood tests may include an FBC, a metabolic panel, liver function tests, albumin, iron studies, nail clippings for fungal microscopy, culture and sensitivities and, if indicated on history, a heavy metal screen. Treatment of the identified underlying aetiology can lead to resolution of the nail changes with time. Diligent nail care, limitation of exposure to irritants and frequent moisturising can all assist in the return to a normal nail. For example, onycholysis as a cause of pseudoleukonychia may be managed by keeping the nails trimmed short and avoiding moist environments, trauma and contact irritants. Mechanical cleaning under the nails should be discouraged to prevent introduction of infection. trauma to the matrix (eg, overzealous manicuring) and a subsequent fault in keratinisation. It is not due to zinc or calcium deficiency as is often believed. Punctate leukonychia has also been described in association with alopecia areata. About half of the lesions will disappear as the nail grows towards the free edge. igation and referral. Definitive diagnosis of subungual melanoma requires biopsy. Clinical examination Dermoscopic features of melanoma involving the nail plate may include brown pigmentation with various darker bands within the lesion. These bands are often more irregular in spacing and width than in naevi and lentigo.9 Hutchinson’s sign of the nail refers to extension of pigment onto the proximal or lateral nail fold and is a concerning sign requiring further investigation. It can occur in subungual naevi but is more commonly seen in melanoma (figure 4). Change in longitudinal melanonychia, which should be closely monitored, should prompt specialist referral for urgent consultation. discolouration of the skin and nails of fingers used to hold cigarettes. Smoking cessation may result in a clear line of demarcation with tar staining evident in the distal nail and absent proximally (also known as ‘quitter’s nail’). Henna, used for cultural and cosmetic purposes, may also cause brown staining of the skin and nails. Following prolonged use of nail varnish, a light-brown or yellow discolouration may occur in the affected nails if it is not removed frequently. This is temporary and will grow out. Haematoma Exogenous pigment is a common cause of brown chromonychia. Nicotine may cause brown-orange Traumatic nail injury causing subungual haemorrhage may result in red-brown dyspigmentation in the acute phase or brown-black discolouration if chronic as a result of haemosiderin deposition. The patient may or may not be aware of a history of trauma. Dermoscopically, haemorrhage may appear red, brown or black and has central pigment homogeneity. Round droplets may be present near the edges of the nail plate, and splinter haemorrhages may also be seen. In the event of a large traumatic haematoma, pressure can be released though the slow insertion of a sharp, heated sterile implement (such as the end of a paperclip) just distal to the lunula. No treatment expedites clearance of haemosiderin. The affected nail will migrate distally at the same rate as normal nail growth (0.1mm/day), eventually separating and falling off by itself or being intentionally clipped. be a common incidental finding in children and adolescents who do not notice minor injury to nails. The abnormality is transient and grows out with the growth of new nail. treatment for the leukonychia seen in Darier’s and Hailey-Hailey disease although it may improve with management of aggravating factors and prevention of complications. Longitudinal leukonychia Apparent leukonychia Longitudinal leukonychia is a permanent greyish-white longitudinal streak 1mm wide. It may develop as a single streak on a single nail, affect two or three nails, or present as several striae down one nail. Isolated longitudinal leukonychia is uncommon and may reflect an underlying nail-bed tumour, such as a subungual filamentous tumour. A horny pearl of keratinous substance will be seen under the free edge of the nail in a subungual filamentous tumour. If pain or nail splitting develops, surgical excision may be required, wherein the nail bed is exposed and the lesion is excised before the plate is repositioned. Longitudinal leukonychia may also be seen together with longitudinal erythronychia in Darier’s disease (keratosis follicularis), which is a rare autosomal dominant dermatosis. Hailey-Hailey disease (familial benign chronic pemphigus) may also cause longitudinal leukonychia. This rare inherited condition is associated with the gene ATP2C1 and may present in the second to fourth decade as a painful erosive rash occurring primarily in the flexures. It may become hyperkeratotic and develop secondary bacterial infection, resulting in an associated malodour. There is no Apparent leukonychia, in contrast to true leukonychia, does fade with pressure and does not move distally with nail growth. This is due to the fact that apparent leukonychia is the result of changes in the nail bed rather than the nail matrix itself. Apparent leukonychia may be a sign of systemic disease causing vascular changes, nail-bed hyperkeratosis or interspersed onycholysis. The most commonly seen forms of apparent leukonychia are half-and-half nails, Muehrcke’s nails and Terry’s nails. Anaemia may also manifest with apparent leukonychia if the haemoglobin is sufficiently low. Raynaud’s phenomenon may cause apparent leukonychia due to vasoconstriction. Treatment and prognosis Following the diagnosis of melanoma, treatment will depend on tumour thickness but will often involve amputation of the digit. Prognosis is variable depending on the time of detection and the depth of the tumour. As a result of the delayed diagnosis, the tumour subtype (acral lentiginous, superficial spreading or nodular) is not significantly associated with prognosis. Melanoma in the toenail is typically identified later than melanoma in the fingernail, resulting in a worse prognosis on diagnosis. Brown staining Leukonychia LEUKONYCHIA describes an opaque white discolouration of the nail and is the most common form of chromonychia. While there are a variety of classifications reported, there are three broad subtypes: true leukonychia, apparent leukonychia and pseudoleukonychia.1,10 True leukonychia is the result of matrix dysfunction and resulting defective keratinisation. Light is diffracted abnormally so that normal transparency of the nail is lost, giving it an opaque white appearance. The discolouration moves distally as the nail grows and does not fade with applied pressure. True leukonychia may be categorised, depending on extent and pattern, as complete or total leukonychia; and incomplete or subtotal leukonychia, which includes punctate, transverse and longitudinal leukonychia. Complete leukonychia is rare. It may be inherited or acquired, involve one or multiple digits, and a rare inherited form can involve all 20 nails, appearing porcelain-white in colour. Acquired complete leukonychia is commonly the result of superficial onychomycosis but may rarely be seen in association with peptic ulcer disease, cholelithiasis and ulcerative colitis. The subcategories of incomplete leukonychia are discussed later in this section. Apparent leukonychia is due to an abnormality in the nail bed rather than the nail matrix and therefore does resolve with pressure. Pseudoleukonychia is neither the result of 28 | Australian Doctor | 14 November 2014 Punctate leukonychia Punctate leukonychia is the most common form of true leukonychia. It describes the presence of white spots on the nail plate and is found most commonly in the fingernails. It is thought to be due to local micro- Transverse leukonychia Mees’ lines Mees’ lines are transverse homogenous white bands, 1-2mm wide, across the entire nail. First described by Mees in 1919 in association with arsenic toxicity, transverse leukonychia can develop on one or several nails. It occurs at the same level in each nail, and the proximal and distal borders are parallel throughout their width. The distance from the cuticle helps determine the time of the insult. The magnitude of the band indicates disease severity. Any acute systemic illness can cause transverse leukonychia, as can heavy metal toxicity or chemotherapy. Acute rejection of a renal allograft has also been recognised as a cause.11 Leukonychia variegata This is a variant of transverse leukonychia. The white transverse bands are not uniform and result from repeated microtrauma to the nail matrix (eg, from a distally impinged shoe on an untrimmed nail). These striae are less homogeneous than the transverse leukonychia caused by endogenous pathology and can www.australiandoctor.com.au Half-and-half nail Half-and-half nail (‘Lindsay nail’) is associated with chronic renal failure — in particular, uraemia. The proximal half of the nail is pale or white and obscures the lunula while the nail is erythematous distally. There is a red/pink or brown band at the junction of the colour change due to increased lipochrome pigment deposition. The nail discolouration may cont’d page 30 How To Treat – Nail discolouration from page 28 resolve with correction of renal function and often resolves within weeks of renal transplantation in affected individuals.12,13 Terry’s nail Terry’s nail was first described in patients with cirrhosis.14 Like halfand-half nails, all nails tend to be affected uniformly, with proximal opaque white discolouration that obscures the lunula and extends distally to end 1-2mm from the distal edge, leaving an area of normallooking nail. In some patients, the proximal nail bed is light pink rather than white. These changes are attributed to alterations in the underlying vascularity and are seen in cirrhosis, hepatic metastases, congestive cardiac failure and type 2 diabetes mellitus. In contrast to half-and-half nails, there is no brown band at the junction between the white discolouration and the distal area of erythema. Treatment of the underlying disease process may alter the appearance of the nail, but the vascular changes often persist. Muehrcke’s lines Muehrcke’s lines are a double band of white lines running parallel to the lunula and are separated by pink bands of normal-looking nail. They are classically seen in association with conditions that cause hypoalbuminaemia (<2g/dL), such as nephrotic syndrome, hepatic failure and malnutrition.31 Muehrcke’s lines have also been reported in patients receiving systemic chemotherapy and patients with zinc deficiency. It is thought to be the result of oedema of the connective tissue in front of the lunula, below the epidermis. Figure 5: Onycholysis due to psoriasis causing pseudoleukonychia in the distal fingernails. Recovery of serum albumin level leads to a return to normal nails; thus, correction of the underlying disorder and/or replacement of albumin is the treatment of choice. Pseudoleukonychia Pseudoleukonychia occurs following alteration of the nail plate rather than the matrix by external causes. It can be seen in onychomycosis (superficial or subungual) or granulation of the nail keratin after the long-term application of nail enamel. Onycholysis may also masquerade as leukonychia. Separation of the nail plate from the nail bed allows air to pass beneath the nail plate and may cause the onycholytic portion of the nail plate to appear white. Many conditions are associated with onycholysis, including psoriasis (figure 5), eczema, thyrotoxicosis, lichen planus and pregnancy.1,15 Local irritation or injury to the nail can cause onycholysis, such as excessive local trauma from manicuring, allergic or irritant contact dermatitis, chemical overexposure with cosmetic manicures or prolonged exposure to wet environments. Drugs can also irritate the nail and precipitate onycholysis — in particular, chemotherapeutic agents, oral retinoids, the oral contraceptive pill, antipsychotics (olanzapine and aripiprazole) and those that interact with sunlight, such as the tetracyclines.1,3 Onycholysis predisposes nails to secondary subungual infections from dermatophytes, yeasts or bacterial infections, including Pseudomonas aeruginosa and Staphylococcus aureus.7 Blue or green Pseudomonal infection GREEN-BLACK discolouration of the nail plate is often indicative of infection with P. aeruginosa (figure 6). Any insult that disrupts the nail architecture may allow this organism to colonise under the nail plate. The green tinge is due to accumulation of pyocyanin and pyoverdin, a pigment that adheres to the undersurface of the nail plate. It is often seen in conjunction with onycholysis or chronic paronychia, and may also be associated with onychomycosis. The management of pseudomonal nail infection should begin with treating any underlying disorder, such as onychomycosis or paronychia. Pseudomonal infection often coexists with candida and aspergillus, especially in the diabetic patient. If candida is cultured from the nail plate, oral antifungals should be administered. The general treatment of paronychia includes good skin care and Figure 6: Characteristic green-black chromonychia of pseudomonal nail infection. once or twice daily. Cutting the detached portion of the nail may be necessary to expose the infected area and to keep the nail dry. Topical tobramycin drops (using the eye formulation) have been reported to successfully treat subungual pseudomonal infection.16 Failure of conservative management may necessitate removal of the nail plate. Argyria general hand/foot hygiene. Avoid the use of soap and detergents and wear protective gloves for all wet and contaminated work. Regular application of hand moisturiser to maintain the skin barrier function is recommended. In the event of nailfold inflammation, the daily application of a topical steroid (short term), such as mometasone ointment, is beneficial. Systemic antibiotics are often ineffective in the treatment of the pseudomonal infection. Pseudomonas thrives in a wet alkaline environment. Daily acetic acid (1%) soaks may help suppress pseudomonal growth: the patient should be advised to dilute white vinegar with water to 1:20, soak the affected hand or foot for 10-15 minutes in the solution and then dry thoroughly. This should be done Argyria is a rare condition characterised by blue discolouration of the skin and nails following chronic ingestion of silver. Currently, silver ingestion is rare because the amount of elemental silver in oral medications such as antibiotics has been reduced. However, recently, reported cases of colloidal silver toxicity have occurred in relation to alternative health practices and some commercial water-sterilising devices. Following ingestion, the silver granules are deposited in the skin and lunula of the nail bed, causing a slate-grey blue pigmentation — particularly in sunexposed areas. The pigmentation is permanent. It is important to distinguish argyria from other conditions such as Wilson’s disease, Addison’s disease, haemochromatosis or drugrelated pigmentary changes. Skin biopsy is often necessary. Avoiding sun exposure and using UV-protective measures may reduce further darkening of pigmented skin. Wilson’s Disease Hepatolenticular degeneration occurs secondary due to copper accumulation and may cause a profound blue discolouration of the nail lunula. A golden-brown ring is visible around the corneoscleral junction of the eye in most patients with Wilson’s disease and may distinguish this disease from other causes of blue nails. Traces of copper may be detected in nail clippings and urine. Yellow Onychomycosis ONYCHOMYCOSIS is exceedingly common in toenails and may present with yellow dyschromia of the nail (figure 7). Nail clippings and scrapings of the subungual debris should be sent for fungal microscopy, culture and sensitivities. Management options for onychomycosis include application of topical antifungal agents, often in combination with a urea-based agent to soften the nail. Onychomycosis is notoriously difficult to treat, and oral antifungal therapy is often required to eradicate infections (see table 2). Therefore, intense followup is imperative. Psoriasis Psoriasis can result in nail pitting and ridging, onycholysis, subungual hyperkeratosis and yellow discolouration. Psoriatic nail changes may be seen in 50-60% of patients with psoriasis.1 The fingernails are more commonly affected than the toenails. Severe nail involvement may occur without severe skin disease; however, psoriatic nail changes do have an increased association with psori- 30 | Australian Doctor | 14 November 2014 Figure 7: Yellow discolouration of the toenails as a result of onychomycosis. atic arthritis. Management options for psoriatic nail changes are unfortunately often ineffective (see table 3, next page). Diabetes Diabetic patients may develop thickened nails with yellow discolouration. This is thought to be the result of microangiopathic changes seen in the extremities of diabetic patients. Diabetic patients experience a three fold increased risk of onychomycosis.17 There is no specific treatment once concur- rent onychomycosis has been ruled out. Yellow nail syndrome Yellow nail syndrome is an uncommon condition of unclear aetiology characterised by a triad of thickened yellow nails, lymphoedema and respiratory manifestations.30 This condition presents in adults but may rarely be seen in children. Characteristically, the nails are thick, slowgrowing with diffuse yellow-green discolouration and obscuration of the lunulae (figure 8, see next page). www.australiandoctor.com.au Table 2. Oral antifungal agents used to treat onychomycosis in adults Oral antifungal agent Details of administration Terbinafine 250mg daily with 42 tablets supplied and one repeat. The second course of tablets may be taken twice a week instead of daily, prolonging therapy while still providing adequate dosing. The side effects of oral antifungal agents, while rare, include agranulocytosis and liver function abnormalities; therefore it is recommended to monitor white cell count and liver function during treatment. Itraconazole Pulse therapy with 100-200mg twice daily for the first week of each month for three months. A new formulation is available in 50mg tablets. Fluconazole 150mg weekly for three months. It should be taken until the new nail grows. Griseofulvin 1g daily may be used but is not as effective as other agents. It has a 50% cure rate. It is not a fungicidal agent and thus relapse is common. Cuticles are absent, and increased lateral curvature may be observed along the thickened nail plate with associated subungual hyperkeratosis. A marked bulge is often seen halfway between the distal and proximal nail folds, and the nail plate may not reach the free edge of the digit. It is thought that the yellow colour is due to a combination of hyperkeratosis and lipochrome accumulation and that the structural nail changes are a result of dense stromal sclerosis that replaces the subungual stroma.18 Lymphoedema is the presenting symptom and commonly affects the lower limbs. Patients often present with cough and tachypnoea, Figure 8: Yellow nail syndrome showing characteristic thick nails with diffuse yellow-green discolouration, obscuration of the lunulae and increased lateral curvature. which result from a wide range of pathologies — including pneumonia, bronchiectasis, pleural effusions and sinusitis. Yellow nail syndrome has also been reported in association with immunodeficiency states, TB, breast cancer, cholangiocarcinoma, mycosis fungoides, obstructive sleep apnoea, thyroid disease and rheumatoid arthritis.30 Some patients may experience spontaneous recovery. Topical (twice-daily application to the nail plate) or oral vitamin E (800 units daily for 12-18 months) has been reported to be beneficial in some patients and may lead to clinical improvement.19 Vitamin E is thought to scavenge free radicals and may reduce the accumulation of lipofuscin. The addition of itraconazole or fluconazole may produce better results than oral vitamin E alone.20 Oral zinc replacement may be of benefit. Intralesional triamcinolone to the proximal nail matrix has been reported to be partially effective. (see box, ‘Drugs that may cause yellow chromonychia’). Penicillamine, gold, lithium and antimalarial agents, such as quinacrine and chloroquine, have been reported to cause a diffuse yellow chromonychia in some patients. 14 Tetracycline doses greater than 1g per day may cause fluorescent lunulae and a yellow nail plate.21 Lithium may cause a golden discolouration of the distal nail bed, most commonly affecting the great toe.1 Medication cessation may allow for gradual improvement, but in some cases, yellow chromonychia may persist for many years. Drugs Onychogryphosis Drugs may cause yellow dyschromia Onychogryphosis Table 3. Management options for psoriatic nail changes Type of agent and administration Details and explanation Potent topical steroids applied to the proximal nail fold under occlusive dressing Diprosone ointment rubbed in to the nail fold nocte may be of benefit over a number of months. The fingernail can be covered in plastic wrap for 2-3 hours at a time for a period of one week to enhance absorption. Intralesional steroids Intralesional triamcinolone is sometimes used in those individuals suffering from psoriatic nail changes but with minimal cutaneous psoriasis elsewhere. It is painful and variably effective; as such it is not usually a first-line treatment Oral agents in patients with widespread, cutaneous psoriasis; some oral agents may improve associated nail changes Methotrexate. This is a potent competitive antagonist of dihydrofolate reductase, altering DNA synthesis and T-cell proliferation and migration, resulting in immunosuppressive and anti-inflammatory effects. Possible adverse effects include hepatotoxicity, pulmonary toxicity (especially pneumonitis and fibrosis), nausea, diarrhoea, myelosuppresion, nephrotoxicity and potential immunosuppression-induced malignancy. It is teratogenic and spermatogenic and should be discontinued at least three months prior to conception. Drugs that may cause yellow chromonychia Acitretin. This is a second-generation mono-aromatic oral retinoid that elicits its biological effect through the activation of nuclear receptors and regulation of gene transcription. It is used in the treatment of psoriasis in men of all ages and women who are not of childbearing age. Like all other retinoids, side effects include dry mucous membranes, hyperlipidaemia, teratogenicity, depression and reduced night vision. Tetracycline Penicilliamine Gold Antimalarial agents: quinacrine and chloroquine Cyclosporine. Cyclosporine is a calcineurin inhibitor that reduces T-cell proliferation and may improve cutaneous psoriasis more rapidly than other oral agents. Adverse effects include hypertension, renal toxicity, tremor, headache, hypertrichosis, hyperkalaemia and hyperlipidaemia. Often long-term use is limited by its nephrotoxicity. Lithium describes the Biologic agents. These agents have revolutionised the treatment of severe, recalcitrant psoriasis. The PBS provides rebates for patients over 18 years of age, who have had symptoms for more than six months from the time of initial diagnosis and have failed to achieve adequate response (based on PASI score) to three systemic treatments (ie, methotrexate, cyclosporine, narrow band ultraviolet B phototherapy) following a minimum trial of six weeks of each treatment. Biologic agents available in Australia include: Anti-TNF agents • Etanercept • Infliximab • Adalimumab Ani-IL12/23 agents • Ustekinumab thickening and lengthening of the nail plate that may result in distortion of the nail mimicking a ram’s horn. Such distortion may result in an apparent chromonychia with a yellow-brown appearance. The elderly and neglected are commonly affected, but it may also be associ- Red or orange Online resources THE red nail, or erythronychia, is the result of inflammation, vascular proliferation or thinning of the nail plate, all rendering the vasculature of the nail bed more visible. Nails can be affected individually or collectively. Fingernails are more commonly affected than toenails. Figure 9: Longitudinal erythronychia in the finger. The underlying cause turned out to be a benign pseudomyxoid cyst. Splinter haemorrhage Splinter haemorrhages are common, resulting from longitudinal haemorrhage in the nail bed. They often occur distally and may affect one or multiple nails. Trauma is the most common cause, which explains why they are often seen on the dominant hand. Other conditions associated with splinter haemorrhages include onychomycosis, psoriasis and dermatitis. Extensive involvement of multiple digits of the hands and feet may be caused by systemic conditions such as bacterial endocarditis or antiphospholipid syndrome. Recognition of associated stigmata may facilitate the diagnosis. Splinter haemorrhages may also be associated with the use of thrombolytics, anticoagulants, the oral contraceptive pill, tetracyclines, ganciclovir and taxanes.22 Longitudinal erythronychia Longitudinal erythronychia is a linear red band along the nail plate originating proximally (figure 9). It occurs as a result of thinning of ated with trauma or psoriasis. Treatment involves hand hygiene and good nail care; however, nails may remain hyperkeratotic for months. New monodactylous longitudinal erythronychia require close monitoring, and if evolving, a biopsy of the nail fold should be performed to investigate for local malignancy. the overlying nail plate because of a focal defect in the germinal nail matrix. This allows the underlying vasculature to be more visible, resulting in a longitudinal red band. It may occur directly as a result of nail matrix disease or secondary to pressure on the matrix — as seen with myxoid cyst, glomus tumour or onychopapilloma. More than one nail may have longitudinal erythronychia, and more than one band may develop in a single nail. Polydactylous longitudinal erythronychia is suggestive of a systemic disorder, such as lichen planus, Darier’s disease, amyloidosis or coeliac disease. Monodactylous longitudinal erythronychia may be caused by an underlying systemic disease but is more commonly the result of a benign www.australiandoctor.com.au tumour (verruca, glomus tumour, myxoid cyst) or a malignant process, such as squamous cell carcinoma in situ, melanoma in situ or basal cell carcinoma. New monodactylous longitudinal erythronychia require close monitoring, and if evolving, a biopsy of the nail fold should be performed to investigate for local malignancy. Darier’s disease Darier’s disease, or keratosis follicularis, is a rare autosomal dominant condition causing greasy hyperkeratotic papules in seborrhoeic regions. About 90% of patients with Darier’s disease will have nail involvement, with the fingernails more affected than the toenails.23 There may be subungual hyperkeratosis, and V-shaped notches classically develop in the distal free edge of the nail. Keratotic papules may be found over the proximal nail fold along with palmar pits. Several bands of red and white longitudinal striae are frequently seen in the nail plate. Glomus tumour The glomus body of the nail acts as a thermoregulatory shunt in the peripheries between the arterioles and venules. Glomus tumours are rare benign hypervascular neoplasms arising from the glomus body. It frequently affects adults cont’d next page • www.dermnetnz.org • www.emedicine.com/derm/ • www.aafp.org • www.bad.org.uk References Available on request from [email protected] Declaration of interest statement There are no conflicts of interest to declare. Acknowledgement The authors thank Mr Rodrigo Martell for the production of the medical illustration in figure 1. Photographic images were the author’s own. 14 November 2014 | Australian Doctor | 31 How To Treat – Nail discolouration from previous page between 20 and 40 years of age. It most commonly occurs subungually but may be seen on the finger or toe pulps. Women are more frequently affected than men, and 75% of cases involve the hand.1 The tumour causes a light-red or blue discolouration of the overlying nail with linear erythronychia extending distally (figure 10). It may be extremely painful, and local application of ice will exacerbate the pain. Ultrasound or MRI may confirm the clinical suspicion and assess size preoperatively. Glomus tumours are benign; however, surgical treatment is often mandated because of pain. Histological examination of the excised tumour is required to confirm the diagnosis. Red lunulae Red lunula may be caused by many cutaneous or systemic disorders and usually affects the thumb (see table 4). Dotted red lunulae may be seen in patients with psoriasis and alopecia areata. The pathogenesis remains undetermined. Conclusion A DISCOLOURATION of the nails is a common presentation in general practice. Its causes are numerous and while often benign, may be a sign of underlying systemic disease or malignancy. Identification of a concerning presentation, such as new longitudinal melanonychia or Hutchinson’s sign of the nail, requires prompt referral to a dermatology service for biopsy and further management. For patients who live in communities without good access to dermatologists, consideration may be given to taking a biopsy locally in consultation with a dermatologist. Orange chromonychia Kawasaki disease is a rare febrile vasculitis of childhood classically affecting children under five years of age. Following the acute febrile phase, transverse orange-red dyschromia may be seen in multiple nails followed by the development of Beau’s lines.24,25 These areas do not blanch under pressure and usually resolve over a period of weeks. B Table 4. Conditions that may cause red lunulae1 Clinical system Conditions Cardiovascular Atherosclerosis, hypertension, congestive cardiac failure Pulmonary Chronic obstructive pulmonary disease Haematological Hodgkin’s disease, myeloid leukaemia, polycythemia rubra vera Dermatological Alopecia areata, chronic urticaria, psoriasis, trachyonichia, vitiligo Endocrine Diabetes, hyperthyroidism Hepatic Cirrhosis Infectious Pneumonia, tuberculosis Other Alcohol abuse, carbon monoxide poisoning Figure 10: Subungual glomus tumour in the finger. A: Initial presentation of the tumour showing a discrete erythematous area under the nail plate with overlying onycholysis. B: The glomus tumour exposed on removal of the nail plate and retracting the nail fold. Instructions How to Treat Quiz Complete this quiz online and fill in the GP evaluation form to earn 2 CPD or PDP points. We no longer accept quizzes by post or fax. The mark required to obtain points is 80%. Please note that some questions have more than one correct answer. Nail discolouration — 14 November 2014 1. Which TWO statements are correct regarding the anatomy and physiology of the nail unit? a) Toenails grow at an average rate of 0.1mm per day b) The nail bed is responsible for the majority of nail production c) The lunula is the distal aspect of the germinal matrix d) Nail rigidity is due to hard keratins comprised primarily of sulfur bonds 2. Which TWO statements are correct regarding melanonychia? a) Melanonychia is usually malignant b) Malignant melanonychia can only be caused by melanoma not other types of skin cancers c) Systemic causes of melanonychia include hyperthyroidism, Addison’s disease and Cushing’s syndrome d) Antibiotics can cause melanonychia 3. Which THREE clinical characteristics of longitudinal melanonychia are red flags for melanoma? a) It begins in a single digit during the fourth to seventh decade of life b) It is associated with Hutchinson’s sign of the nail c) It has blurred not straight lateral borders d) It is wider distally than proximally GO ONLINE TO COMPLETE THE QUIZ www.australiandoctor.com.au/education/how-to-treat 4. W hich TWO statements are correct regarding melanoma as a cause of melanonychia? a) M elanoma involving the nail plate is most commonly seen in late teenage years or early adulthood b) D ermoscopically observed dark bands in melanonychia are often more irregular in spacing and width than in naevi and lentigo c) T reatment of melanoma in the nail often involves amputation of the digit d) P rognosis of melanoma in the nail depends on the tumour subtype hepatic metastases, congestive cardiac failure and type 2 diabetes mellitus c) Muehrcke’s lines are a double band of white lines running parallel to the lunula typically associated with onychomycosis d) Onycholysis as a cause of pseudoleukonychia may be managed by keeping the nails trimmed short and avoiding moist environments, trauma and contact irritants 5. W hich TWO statements are correct regarding true leukonychia? a) T rue leukonychia is caused by an abnormality in the nail bed and resolves with pressure b) P unctate leukonychia is due to zinc or calcium deficiency c) T ransverse leukonychia may be caused by an acute systemic illness d) Isolated longitudinal leukonychia may reflect an underlying subungual filamentous tumour 7. Which THREE statements are correct regarding the clinical approach to leukonychia? a) History-taking should include occupational history, family history, drug history and history of exposure to heavy metals b) Examination should look for signs of liver or renal failure c) Screening tests may include an FBC and iron studies d) First-line treatment of true leukonychia is a strong topical corticosteroid daily for three months 6. W hich THREE statements are correct regarding apparent leukonychia and pseudoleukonychia? a) H alf-and-half nail is associated with chronic renal failure and uraemia b) T erry’s nails are associated with cirrhosis, 8. Which ONE statement is correct regarding blue-green chromonychia? a) Green-black chromonychia is usually caused by hepatolenticular degeneration b) Pseudomonal infection causing nail discolouration should be treated initially with systemic antibiotics c) Wilson’s disease causes blue discolouration of the lunula only d) Nail discolouration caused by argyria is reversible by chelation therapy 9. Which TWO statements are correct regarding yellow chromonychia? a) Yellow nail discolouration may be caused by onychomycosis, onychogryphosis and psoriasis in the nails b) Diabetic patients with yellow chromonychia should be started on a high-protein diet c) Yellow nail syndrome is a benign racial pigmentary syndrome with no associated comorbidities d) Drugs that may cause yellow chromonychia include tetracyclines and lithium 10. Which TWO statements are correct regarding conditions associated with red or orange chromonychia? a) Splinter haemorrhages are diagnostic for bacterial endocarditis b) Longitudinal erythronychia in multiple fingers may suggest underlying amyloidosis or coeliac disease c) Dotted red lunulae are caused by basal cell carcinoma d) Transverse orange-red chromonychia may be associate with Kawasaki disease CPD QUIZ UPDATE The RACGP requires that a brief GP evaluation form be completed with every quiz to obtain category 2 CPD or PDP points for the 2014-16 triennium. You can complete this online along with the quiz at www.australiandoctor.com.au. Because this is a requirement, we are no longer able to accept the quiz by post or fax. However, we have included the quiz questions here for those who like to prepare the answers before completing the quiz online. Next week 32 how to treat Editor: Dr Steve Liang Email: [email protected] Chronic obstructive pulmonary disease is a common condition seen in general practice and causes significant morbidity and mortality. The next How to Treat reviews the clinical approach to COPD with particular focus on information given by the soon-to-be-published COPD-X Concise Guide for Primary Care developed by Lung Foundation Australia in conjunction with the Thoracic Society of Australia and New Zealand. The authors are members of the Lung Foundation Australia COPD Coordinating Committee, and Writing Committee for the COPD Concise Guide: Associate Professor Ian Yang, Professor Peter Frith, Dr Kerry Hancock, Professor Christine McDonald, Elizabeth Harper, and Professor Michael Abramson. | Australian Doctor | 14 November 2014 www.australiandoctor.com.au